Posts in the “Featured OnlyFeatured Only Archives - Page 2 of 2 - ALCMI - Addario Lung Cancer Medical Institute” category:

Genomics of Young Lung Cancer and INHERIT Studies Accepted for Presentation at ASCO

Posted by Bradley Newton on May 13th, 2015 |

Two Addario Lung Cancer Medical Institute research studies funded in part by the Bonnie J. Addario Lung Cancer Foundation chosen for presentation at the May/June 2015 American Society of Clinical Oncology Annual Meeting

International Partnership to Address Lung Cancer Epidemic

Posted by Bradley Newton on February 10th, 2015 |

According to a recent study in the Annals of Oncology, lung cancer fatalities are set to overtake breast cancer deaths among European women for the first time this year. It is predicted lung cancer deaths for women in Europe will reach 14.24 per 100,000 of the population in 2015.

ALCMI Launches Genomics of Young Lung Cancer Study

Posted by Steven Young on February 5th, 2015 |

The Addario Lung Cancer Medical Institute (ALCMI) today launched a new study, the Genomics of Young Lung Cancer, to understand why lung cancer occurs in young adults, who quite often are athletic, never smokers and do not exhibit any of the known lung cancer genetic mutations.

Exosome Diagnostics & ALCMI Announce Collaboration on Sequencing Blood

Posted by Steven Young on December 8th, 2014 |

CAMBRIDGE, Mass. and LOS ANGELES, Calif., Jan. 9, 2015 – Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced a strategic collaboration with the Addario Lung Cancer Medical Institute (ALCMI) to accelerate the development of its lead plasma-based diagnostics in development for mutation detection and monitoring in patients with lung cancer. The […]